Screener
AngioDynamics ANGO Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Total other income, net | 3,627 | 5,922 | 797 |
| Loss before income tax expense (benefit) | (36,300) | (34,032) | (191,638) |
| Income tax expense (benefit) | 442 | (39) | (7,289) |
| Net loss | $(36,742) | $(33,993) | $(184,349) |
| Loss per share | |||
| Basic | $(0.88) | $(0.83) | $(4.59) |
| Diluted | $(0.88) | $(0.83) | $(4.59) |
| Weighted average shares outstanding |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's net income?
- AngioDynamics (ANGO) reported net income of -$11.41M in Q1 2026.
- How has AngioDynamics's net income changed year-over-year?
- AngioDynamics's net income decreased by 88.5% year-over-year, from -$6.05M to -$11.41M.
- What is the long-term trend for AngioDynamics's net income?
- Over 4 years (2022 to 2026), AngioDynamics's net income has grown at a 2.5% compound annual growth rate (CAGR), from -$33.29M to -$36.74M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about AngioDynamics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude